UPDATE 2-Endo's $2.2 bln offer could complicate Auxilium Pharma's QLT deal
(Adds details, CEO quote; updates shares)
By Shailaja Sharma
Sept 16 (Reuters) - Endo International Plc made an unsolicited offer to buy Auxilium Pharmaceuticals Inc for about $2.2 billion, which analysts said could complicate Auxilium's buyout of Canadian eye drug maker QLT Inc .
Endo Chief Executive Rajiv De Silva said the specialty healthcare company sent its offer to Auxilium on Friday but had not received an official response.
Auxilium did not respond to an email query and phone calls. The Chesterbook, Pennsylvania-based company said in June that it would buy Vancouver-based QLT in an all-stock deal in order to move its headquartersto lower-tax British Columbia.
Auxilium said it expected that buyout to be completed in the fourth quarter of 2014.
Endo's offer of $28.10 per share in cash and stock represented a premium of 30.6 percent to Auxilium's Tuesday closing price of $21.52 on the Nasdaq.
Auxilium's shares were up 37 percent at $29.52 after the bell, indicating that some shareholders expected a higher offer.
"Our offer is for Auxilium only," De Silva said during a conference call late on Tuesday. He was responding to analysts who asked if the deal could throw into doubt Auxilium's takeover of QLT. Continued...